Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone (Q79750875)
Jump to navigation
Jump to search
scientific article published on 01 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone |
scientific article published on 01 February 2007 |
Statements
Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone (English)
Stephan Puls
Indre Offermann
1 February 2007